Trial Condition(s):
Acute Ischemic Stroke
A first-in-human study to learn how safe the study treatment BAY3018250 is, how it affects the body, how it moves into, through, and out of the body, and what it does in healthy men when given in single, increasing doses compared to placebo
Bayer Identifier:
21751
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
2022-500505-41
Not Yet Recruiting
Trial Purpose
Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
N/A
Trial Dates
Phase
1
Could I receive a placebo?
No
Products
BAY3018250
Accepts Healthy Volunteers
N/A
Where to Participate
Loading...
Locations
Status
| Locations | Status | |
|---|---|---|
Locations CRS Clinical Research Services Wuppertal GmbH Wuppertal, Germany, 42113 | Status Not yet recruiting | Contact Us: E-mail: [email protected] Phone: (+)1-888-84 22937 |
For details, please refer to trial results
Additional Information
Not Available
Copyright © Bayer
Powered by
